CIK 0001061983 · Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 943291317
- Phone
- (650) 624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- 4 Grant or award Director acquired 7,333 shares (grant or award)
- 4 Planned sale President & CEO sold 5,000 shares at $30.93 ($154,650)
- 8-K Event Shareholder vote results
- 4 Planned sale Director sold 1,454 shares at $29.73 ($43,227)
- 4 Grant or award Director acquired 7,333 shares (grant or award)
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 7,333 shares (grant or award)
- 4 Grant or award Director acquired 7,333 shares (grant or award)
- 4 Grant or award Director acquired 7,333 shares (grant or award)
- 4 Grant or award Director acquired 7,333 shares (grant or award)
- 4 Grant or award Director acquired 7,333 shares (grant or award)
- 4 Grant or award Director acquired 7,333 shares (grant or award)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale EVP Research & Development sold 2,000 shares at $35.01 ($70,020)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale EVP, Chief Commercial Officer sold 4,002 shares at $36.68 ($146,793)
- 8-K Event Other events
- 4 Planned sale President & CEO sold 5,000 shares at $40.96 ($204,800)
- 4 Planned sale EVP Research & Development sold 2,000 shares at $38.11 ($76,220)
Page 14 of 127 · 2,534 filings